Business
Interim Results for the Half-Year to 30 June ...
Igraine Plc announced its unaudited interim results for the six months ended 30 June 2025. The company reported a total loss attributable to equity holders of £(125,752) compared to a loss of £(67,402) for the same period in 2024. Other operating income amounted to £13,448, while administrative expenses totaled £(104,381). The company's investments were valued at £57,626 as of 30 June 2025, compared to £234,219 on 30 June 2024. Cash and cash equivalents stood at £33,330. Total assets were £246,810 and total liabilities were £295,445. Subsequent to the period end, Fixit Medical Ltd, an investee company, completed a director financing, resulting in the Company’s holding being revalued at £499,100. Disclaimer*
About this update from Ethtry Plc
[{"type":"text","content":"\n\n \n \n\n\n\n\nTHE DIRECTORS OF IGRAINE PLC CONSIDER THIS ANNOUNCEMENT TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO. 594/2014 OF THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 16 APRIL 2014 ON MARKET ABUSE AS IT FORMS PART OF RETAINED EU LAW AS DEFINED IN THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. BY PUBLICATION OF THIS ANNOUNCEMENT, THE INFORMATION SET OUT WITHIN IT IS DEEMED NOW TO BE IN THE PUBLIC DOMAIN.26 September 2025Igraine Plc(“Igraine” or “the Company”)Interim Results for the Half-Year to 30 June 2025Igraine plc, Directors Statement,Igraine Plc, the investment issuer focused on opportunities within the alternative energy and the life sciences and breakthrough technologies sectors is pleased to announce its unaudited interim results for the six-month period ended 30 June 2025. These interim results reflect the Company’s ongoing investment activities and financial position during the period under review. The Board continues to monitor opportunities aligned with Igraine’s investment strategy and will update shareholders as appropriate.The interim financial statements for the 6 months ended 30 June 2025 have not been reviewed or audited.On behalf of the BoardDavid LevisDirector and Chief Executive Officer The Directors of the Company, who have issued this RIS announcement after due and careful enquiry, accept responsibility for its content.EnquiriesCompany:David Levis (Chief Executive Officer)Investor relations : [email protected] Growth Market Corporate AdviserPeterhouse Capital LimitedGuy Miller / Mark AnwylTel: +44 (0) 207 469 0930INTERIM INCOME STATEMENT (UNAUDITED)For the period ended 30 June 2025\t\t\t\t\t\t\t\t\t\t\t\tIgraine plc\t\t\t\t\t\t\t\t\t\t\t\t\t6 mths to\t\t\t\t\t\t6 mths to\t\t\t\t\t\t\t\t\t\t\t\t\t30 June\t\t\t\t\t\t30 June\t\t\t\t\t\t\t\t\t\t\t\t\t2025\t\t\t\t\t\t2024\t\t\t\t\t\t\t\t\t\t\t\t\t£ GBP\t\t\t\t\t\t£ GBP\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tRevenue\t\t\t\t\t\t-\t\t\t\t\t\t-\t\t\t\t\t\t\tCost of Sales\t\t\t\t\t\t-\t\t\t\t\t\t-\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tGross Profit/(Loss)\t\t\t\t\t\t- \t\t\t\t\t\t- \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tOther Operating Income\t\t\t\t\t\t13,448 \t\t\t\t\t\t- \t\t\t\t\t\t\tGain/(Loss) on revaluation of investments\t\t\t\t\t\t(34,819)\t\t\t\t\t\t37,581\t\t\...